41 related articles for article (PubMed ID: 38689550)
21. Predictors of tumor-infiltrating lymphocyte efficacy in melanoma.
Zikich D; Schachter J; Besser MJ
Immunotherapy; 2016; 8(1):35-43. PubMed ID: 26653685
[TBL] [Abstract][Full Text] [Related]
22. Adoptive cell transfer (ACT) of autologous tumor-infiltrating lymphocytes (TILs) to treat malignant melanoma: the dawn of a chimeric antigen receptor T (CAR-T) cell therapy from autologous donor.
Roncati L; Palmieri B
Int J Dermatol; 2020 Jul; 59(7):763-769. PubMed ID: 32441324
[TBL] [Abstract][Full Text] [Related]
23. White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.
Weber J; Atkins M; Hwu P; Radvanyi L; Sznol M; Yee C;
Clin Cancer Res; 2011 Apr; 17(7):1664-73. PubMed ID: 21325070
[TBL] [Abstract][Full Text] [Related]
24. Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions.
Granhøj JS; Witness Præst Jensen A; Presti M; Met Ö; Svane IM; Donia M
Expert Opin Biol Ther; 2022 May; 22(5):627-641. PubMed ID: 35414331
[TBL] [Abstract][Full Text] [Related]
25. Tumor-Infiltrating Lymphocytes: Clinical Experience.
Besser MJ; Shapira-Frommer R; Schachter J
Cancer J; 2015; 21(6):465-9. PubMed ID: 26588677
[TBL] [Abstract][Full Text] [Related]
26. Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option.
Rohaan MW; van den Berg JH; Kvistborg P; Haanen JBAG
J Immunother Cancer; 2018 Oct; 6(1):102. PubMed ID: 30285902
[TBL] [Abstract][Full Text] [Related]
27. Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma.
Klobuch S; Seijkens TTP; Schumacher TN; Haanen JBAG
Nat Rev Clin Oncol; 2024 Mar; 21(3):173-184. PubMed ID: 38191921
[TBL] [Abstract][Full Text] [Related]
28. Adoptive cell therapy for the treatment of patients with metastatic melanoma.
Rosenberg SA; Dudley ME
Curr Opin Immunol; 2009 Apr; 21(2):233-40. PubMed ID: 19304471
[TBL] [Abstract][Full Text] [Related]
29. Surgical Considerations for Tumor Tissue Procurement to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.
Mullinax JE; Egger ME; McCarter M; Monk BJ; Toloza EM; Brousseau S; Jagasia M; Sarnaik A
Cancer J; 2022 Jul-Aug 01; 28(4):285-293. PubMed ID: 35880938
[TBL] [Abstract][Full Text] [Related]
30. Tumor-infiltrating lymphocytes in melanoma.
Lee S; Margolin K
Curr Oncol Rep; 2012 Oct; 14(5):468-74. PubMed ID: 22878966
[TBL] [Abstract][Full Text] [Related]
31. Focus on adoptive T cell transfer trials in melanoma.
Hershkovitz L; Schachter J; Treves AJ; Besser MJ
Clin Dev Immunol; 2010; 2010():260267. PubMed ID: 21234353
[TBL] [Abstract][Full Text] [Related]
32. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic.
Duong CP; Yong CS; Kershaw MH; Slaney CY; Darcy PK
Mol Immunol; 2015 Oct; 67(2 Pt A):46-57. PubMed ID: 25595028
[TBL] [Abstract][Full Text] [Related]
33. At the bedside: adoptive cell therapy for melanoma-clinical development.
Weber JS
J Leukoc Biol; 2014 Jun; 95(6):875-82. PubMed ID: 24732024
[TBL] [Abstract][Full Text] [Related]
34. Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer.
Kumar A; Watkins R; Vilgelm AE
Front Immunol; 2021; 12():690499. PubMed ID: 34140957
[TBL] [Abstract][Full Text] [Related]
35. Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future.
Betof Warner A; Corrie PG; Hamid O
Clin Cancer Res; 2023 May; 29(10):1835-1854. PubMed ID: 36485001
[TBL] [Abstract][Full Text] [Related]
36. Adoptive cell transfer therapy for melanoma.
Inozume T
Exp Dermatol; 2023 Mar; 32(3):250-255. PubMed ID: 36382355
[TBL] [Abstract][Full Text] [Related]
37. Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) - Lifileucel (Amtagvi).
Parums DV
Med Sci Monit; 2024 May; 30():e944927. PubMed ID: 38689550
[TBL] [Abstract][Full Text] [Related]
38. Lifileucel: First Approval.
Keam SJ
Mol Diagn Ther; 2024 May; 28(3):339-344. PubMed ID: 38625642
[TBL] [Abstract][Full Text] [Related]
39. Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy.
Betof Warner A; Hamid O; Komanduri K; Amaria R; Butler MO; Haanen J; Nikiforow S; Puzanov I; Sarnaik A; Bishop MR; Schoenfeld AJ
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38423748
[TBL] [Abstract][Full Text] [Related]
40. Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
Svane IM; Verdegaal EM
Cancer Immunol Immunother; 2014 Oct; 63(10):1081-91. PubMed ID: 25099366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
